BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 16708455)

  • 1. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of 1990 Medicaid drug rebate legislation. ASHP Government Affairs Division.
    Am J Hosp Pharm; 1991 Jan; 48(1):114-7. PubMed ID: 2000867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE; Sullivan SD
    Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid program; prescription drugs. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription drug access: not just a Medicare problem.
    Cunningham PJ
    Issue Brief Cent Stud Health Syst Change; 2002 Apr; (51):1-4. PubMed ID: 11977267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceuticals issue brief: pharmaceuticals cost control: year end report--2004.
    Seay M
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-17. PubMed ID: 15724308
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals: pharmacy benefit management regulations--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-9. PubMed ID: 16710927
    [No Abstract]   [Full Text] [Related]  

  • 12. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceuticals: pharmaceutical cost control measures: year end report-2002.
    Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-14. PubMed ID: 12856689
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicaid program; time limitation on price recalculations and recordkeeping requirements under the drug rebate program. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Aug; 68(168):51912-7. PubMed ID: 12962118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceuticals: pharmaceutical cost controls.
    Seay M; Lee LL
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-22. PubMed ID: 17357250
    [No Abstract]   [Full Text] [Related]  

  • 18. Senate committee approves bill to require drug discounts for clinics.
    Wash Memo Alan Guttmacher Inst; 1992 Feb; (4):1-2. PubMed ID: 12284785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projecting future drug expenditures--1994.
    Santell JP
    Am J Hosp Pharm; 1994 Jan; 51(2):177-87. PubMed ID: 8160668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.